About
| Projects | Donations
| Contact
| Links | Home
Table of Contents
1) Workshop Description
2) Acknowledgments
3) Lotsof HS to Dole VP, personal communication, 01.23.03
(redacted)
4) Dole VP to Lotsof HS, personal communication, 02.06.03
5) Dole
VP and Nyswander ME, Heroin Addiction – A Metabolic Disease.
Arch Intern Med 120:19-24, 1967.
6) Federal Regulation of Methadone Treatment, Institute of Medicine.
Chapter 5:120-150, National Academic Press, 1995.
7) Joseph H, Medical Methadone Maintenance:
The Further Concealment
of a Stigmatized Condition. Doctoral thesis, City University of
New York, 1995.
8) Link
BG & Phelen JC, On Stigma and its Public Health Implications.
Columbia University, 2001.
9) Lotsof HS
and Alexander NE, Case Studies of Ibogaine Treatment:
Implications for Patient Management Strategies. The Akaloids,
Vol 56:293-313, Academic Press, 2001.
10) Alper KA,
A Contemporary History of Ibogaine in the United States and
Europe. The Alkaloids, Vol 56:249-282, Academic Press, 2001.
11) Popik
P and Skolnick P, Pharmacology of Ibogaine and
Ibogaine-Related Alkaloids. The Alkaloids, Vol 52:197-231,
Academic Press, 1998.
return to AATOD conference page